CoviLiv
Novel COVID-19 Vaccine Candidate Induces Humoral, Cellular Immunity
A novel intranasal, live-attenuated COVID-19 vaccine candidate appears to induce both humoral and cellular immunity ...
OCTOBER 11, 2023

Load more